Akèy › Kansè nan tete › Kalifòni › Newport Beach
Etid klinik pou Kansè nan tete nan Newport Beach, CA
16 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Newport Beach (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Ap rekriteFaz 1
- Research Site, Newport Beach
IKS014 in Advanced Solid Tumors That Express HER2
Ap rekriteFaz 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Ap rekriteFaz 3
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Hoag Memorial Hospital Presbyterian ( Site 0010), Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ap rekriteFaz 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Ap rekriteFaz 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ap rekriteFaz 1
- Hoag Family Cancer Institute, Newport Beach
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ap rekriteFaz 2/3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
Ap rekriteFaz 1
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- HOAG Memorial Hospital Presbyterian, Newport Beach
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Ap rekriteEtid obsèvasyon
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Ap rekriteFaz 3
- City of Hope Newport Beach, Newport Beach
Perioperative Mindfulness Proposal
Ap rekrite
- Hoag Memorial Hospital Presbyterian, Newport Beach
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Newport Beach
- Kansè Poumon ki pa ti selil14 etid
- Kansè Metastatik10 etid
- BPCO9 etid
- Kansè ovè9 etid
- Kansè Endomèt7 etid
- Kansè poumon7 etid
- Kansè kolorektal6 etid
- Kansè pwostat6 etid
- Kansè tete negatif triple6 etid
- Kansè (tout kalite)6 etid
- Karsinòm selil skuamèz tèt ak kou5 etid
- Kansè renn (Kasinom selil renn)5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.